KIORA PHARMACEUTICALS, INC. (KPRX) Net income 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.8MFY2025 · since FY2016: -$13.3M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -401.4% |
| FY2024 | $3.6M | +128.7% |
| FY2023 | -$12.5M | +7.9% |
| FY2022 | -$13.6M | +1.4% |
| FY2021 | -$13.8M | -100.7% |
| FY2020 | -$6.9M | +3.3% |
| FY2019 | -$7.1M | +34.4% |
| FY2018 | -$10.8M | +18.2% |
| FY2017 | -$13.2M | +0.9% |
| FY2016 | -$13.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Operating cash flowKPRX Free cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →